Hanmi Pharm. Co., Ltd.
128940
Rank in Stocks
#4356
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Share Price
$279.16
Market Cap
$3.54B
Change (1 day)
-2.37%
Change (1 year)
14.50%
Country
KR
Trade Hanmi Pharm. Co., Ltd. (128940)
Category
Healthcare
P/B ratio for Hanmi Pharm. Co., Ltd. (128940)
P/B ratio as of October 2026 TTM: 3.41
According to Hanmi Pharm. Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 3.41. At the end of 2024 the company had a P/B ratio of 3.28.
P/B ratio history for Hanmi Pharm. Co., Ltd. from 2010 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 3.41 | -26.30% |
| 2025 | 4.63 | 41.29% |
| 2024 | 3.28 | -31.05% |
| 2023 | 4.76 | 11.71% |
| 2022 | 4.26 | 1.30% |
| 2021 | 4.20 | -30.24% |
| 2020 | 6.02 | 22.45% |
| 2019 | 4.92 | -32.09% |
| 2018 | 7.24 | -19.42% |
| 2017 | 8.99 | 104.30% |
| 2016 | 4.40 | -60.04% |
| 2015 | 11.01 | 461.75% |
| 2014 | 1.96 | -20.03% |
| 2013 | 2.45 | -9.44% |
| 2012 | 2.71 | 88.62% |
| 2011 | 1.44 | -32.67% |
| 2010 | 2.13 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 1.9834 | -41.88% |
DE
|
|
| 2.1139 | -38.05% |
DE
|
|
| 1.3124 | -61.54% |
JP
|
|
| 6.3468 | 85.99% |
CH
|
|
| 5.0287 | 47.36% |
IN
|
